A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen

Journal of Virological Methods

Volumn 97, Issue 1-2, 2001, Pages 133-149

  Hunt, Ann R ^a   Cropp, C Bruce ^a   Chang, Gwong Jen J ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

ELISA; Japanese encephalitis virus; Recombinant antigen

Indexed keywords

ENVELOPE PROTEIN; FREUND ADJUVANT; IMMUNOGLOBULIN M ANTIBODY; MACROGOL; RECOMBINANT ANTIGEN;

ANIMAL CELL; ARTICLE; CELL ACTIVITY; CELL CULTURE; CELL TRANSFORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PURIFICATION; EPIDEMIC ENCEPHALITIS; HEMAGGLUTINATION; IMMUNOBLOTTING; IMMUNOGENICITY; INTRACELLULAR FLUID; MOUSE; NONHUMAN; PH; PRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERODIAGNOSIS; VIRUS CULTURE;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CENTRIFUGATION, DENSITY GRADIENT; COS CELLS; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; HYDROGEN-ION CONCENTRATION; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MICE; MICE, INBRED ICR; MICROSCOPY, ELECTRON; PLASMIDS; RECOMBINANT FUSION PROTEINS; TRANSFECTION; TRANSFORMATION, GENETIC; VACCINES, SUBUNIT; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

JAPANESE ENCEPHALITIS VIRUS;

EID: 0034900171     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(01)00346-9     Document Type: Article

References (42)

1. A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms
2. Large-scale purification of Japanese encephalitis virus from infected mouse brain for preparation of vaccine
3. Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form
4. Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E
5. Hemagglutination with arthropod-borne viruses
6. A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice
7. Virion and soluble antigens of Japanese encephalitis
8. Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice
9. Epitope model of tick-borne encephalitis virus envelope glycoprotein E: Analysis of structural properties, role of carbohydrate side chain, and conformational changes occurring at acidic pH
10. The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein
11. Flaviviruses
12. Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis
13. Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence
14. Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay
15. Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein
16. Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus
17. Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection
18. A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine
19. Avipox virus-vectored Japanese encephalitis virus vaccines: Use as vaccine candidates in combination with purified subunit immunogens
20. Enzyme-linked immunosorbent assay using recombinant antigen for serodiagnosis of Japanese encephalitis
21. Particulate vaccine candidate for Japanese encephalitis induces long-lasting virus-specific memory T lymphocytes in mice
22. Japanese encephalitis among hospitalized pediatric and adult patients with acute encephalitis syndrome in Hanoi, Vietnam 1995
23. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays (MAC-ELISA) for routine diagnosis of arboviral infections
24. Expression of Japanese encephalitis virus antigens in Escherichia coli
25. Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection
26. Togaviruses, bunyaviruses, and Colorado tick fever
27. Flaviviruses
28. Comparative electrophoretic analysis of the virus proteins of four rhabdoviruses
29. Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis
30. Sindbis vectors suppress secretion of subviral particles of Japanese encephalitis virus from mammalian cells infected with SIN-JEV recombinants
31. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution
32. Isolation and characterization of hybrid cell lines producing monoclonal antibodies directed against the structural proteins of Sindbis virus
33. Identification of epitopes on the E glycoprotein of Saint Louis encephalitis virus using monoclonal antibodies
34. Antibodies to dengue 2 virus E-glycoprotein synthetic peptides identify antigenic conformation
35. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica
36. Chemical and antigenic structure of flaviviruses
37. High-level expression of the Japanese encephalitis virus E protein by recombinant vaccinia virus and enhancement of its extracellular release by the NS3 gene product
38. Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions
39. Comparison of the virion polypeptides of group B arboviruses
40. Proteolytic activation of tick-borne encephalitis virus by furin
41. Structural requirements for low-pH-induced rearrangements in the envelope glycoprotein of tick-borne encephalitis
42. Japanese encephalitis vaccines